Table 2.
Baseline characteristics
| Non-ERP group (n=26) | ERP group (n=51) | p-value | |
|---|---|---|---|
| Age | |||
| Median (range) | 71.5 (49–85) | 68.0 (52–81) | |
| Mean (SD) | 69.8 (8.3) | 67.7 (7.8) | 0.48 |
| Male-to-female ratio | 21:5 | 39:12 | 0.54 |
| Body mass index | |||
| Mean | 26.5kg/m 2 | 27.5kg/m 2 | 0.849 |
| <18.5 (underweight) | 0 | 0 | – |
| 18.5–24.9 (normal) | 9 (35%) | 15 (29%) | 0.67 |
| 25–30 (overweight) | 13 (50%) | 25 (49%) | 0.79 |
| >30 (obese) | 4 (15%) | 11 (22%) | 0.28 |
| ASA grade 2 | 8 | 16 | 0.78 |
| ASA grade 3 | 18 | 35 | 0.83 |
| Preoperative grade | |||
| Grade 1 | 0 | 1 | 0.63 |
| Grade 2 | 1 | 4 | 0.12 |
| Grade 3* | 23 | 41 | 0.79 |
| Carcinoma in situ alone | 1 | 2 | 0.87 |
| Preoperative stage | |||
| <T2 | 12 | 17 | 0.79 |
| ≥T2 | 13 | 32 | |
| Previous open pelvic surgery | 1 | 0 | 0.68 |
| Open cystectomy | 26 | 51 | 0.78 |
| Ileal conduit | 24 | 48 | 0.47 |
| Neobladder | 2 | 3 | 0.32 |
ERP = enhanced recovery programme; SD = standard deviation; ASA = American Society of Anesthesiologists
*
One patient in the non-ERP group and two patients in the ERP group had a cystectomy for significant lower urinary tract symptoms and haematuria. One patient in the ERP group had a cystectomy for extensive adenocarcinoma of the bladder.